These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26769013)

  • 21. Serum Protein Markers for the Early Detection of Lung Cancer: A Focus on Autoantibodies.
    Broodman I; Lindemans J; van Sten J; Bischoff R; Luider T
    J Proteome Res; 2017 Jan; 16(1):3-13. PubMed ID: 27769114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round.
    Pedersen JH; Ashraf H; Dirksen A; Bach K; Hansen H; Toennesen P; Thorsen H; Brodersen J; Skov BG; Døssing M; Mortensen J; Richter K; Clementsen P; Seersholm N
    J Thorac Oncol; 2009 May; 4(5):608-14. PubMed ID: 19357536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening: CT screening for lung cancer: winner confirmed.
    Hutchinson L
    Nat Rev Clin Oncol; 2013 Jul; 10(7):367. PubMed ID: 23752727
    [No Abstract]   [Full Text] [Related]  

  • 24. CT Screening for Lung Cancer: How to Fulfill the Promise.
    Johnstone DW
    Oncology (Williston Park); 2015 Dec; 29(12):950-1. PubMed ID: 26676899
    [No Abstract]   [Full Text] [Related]  

  • 25. Lung cancer screening with low dose computed tomography.
    Baldwin DR; Hansell DM; Duffy SW; Field JK
    BMJ; 2014 Mar; 348():g1970. PubMed ID: 24609921
    [No Abstract]   [Full Text] [Related]  

  • 26. Early Results of Lung Cancer Screening and Radiation Dose Assessment by Low-dose CT at a Community Hospital.
    Jacobs CD; Jafari ME
    Clin Lung Cancer; 2017 Sep; 18(5):e327-e331. PubMed ID: 28237242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinically simplified screening methods to evaluate maximum standard uptake value from F-18-FDG-PET/CT in patients with non-small-cell lung cancer.
    Takeda Y; Miura K; Sato T; Tsujimoto Y; Nagano N; Nagasaka S; Kina S; Sugiyama H
    Medicine (Baltimore); 2018 Jun; 97(26):e11226. PubMed ID: 29952981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computed Tomography Screening for Lung Cancer: Mediastinal Lymph Node Resection in Stage IA Nonsmall Cell Lung Cancer Manifesting as Subsolid and Solid Nodules.
    Flores RM; Nicastri D; Bauer T; Aye R; Andaz S; Kohman L; Sheppard B; Mayfield W; Thurer R; Korst R; Straznicka M; Grannis F; Pass H; Connery C; Yip R; Smith JP; Yankelevitz DF; Henschke CI; Altorki NK;
    Ann Surg; 2017 May; 265(5):1025-1033. PubMed ID: 27232256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limitations of the Lung Cancer Screening Program in the Detection of Small Cell Lung Cancer.
    Biswas A; Khokar A; Jantz MA; Mehta HJ
    J Bronchology Interv Pulmonol; 2017 Oct; 24(4):e48-e51. PubMed ID: 28957893
    [No Abstract]   [Full Text] [Related]  

  • 30. Incidental renal tumours on low-dose CT lung cancer screening exams.
    Pinsky PF; Dunn B; Gierada D; Nath PH; Munden R; Berland L; Kramer BS
    J Med Screen; 2017 Jun; 24(2):104-109. PubMed ID: 28482765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of the tumor size at cure threshold among aggressive non-small cell lung cancers (NSCLCs): evidence from the surveillance, epidemiology, and end results (SEER) program and the national lung screening trial (NLST).
    Goldwasser DL
    Int J Cancer; 2017 Mar; 140(6):1280-1292. PubMed ID: 27925181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance.
    Lou F; Huang J; Sima CS; Dycoco J; Rusch V; Bach PB
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):75-81; discussion 81-2. PubMed ID: 23127371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Reduction in lung cancer mortality by screening programs in smokers--low dose spiral CT is superior to conventional chest X-ray].
    Weiß M
    Rofo; 2014 Jan; 186(1):14. PubMed ID: 24511605
    [No Abstract]   [Full Text] [Related]  

  • 34. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling.
    Wille MM; Dirksen A; Ashraf H; Saghir Z; Bach KS; Brodersen J; Clementsen PF; Hansen H; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thomsen LH; Tønnesen P; Pedersen JH
    Am J Respir Crit Care Med; 2016 Mar; 193(5):542-51. PubMed ID: 26485620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computed tomography or chest radiograph surveillance following stage I non-small cell lung cancer resection?
    Baisi A; Raveglia F; Cioffi U
    J Thorac Cardiovasc Surg; 2015 May; 149(5):1467-8. PubMed ID: 25983259
    [No Abstract]   [Full Text] [Related]  

  • 36. Quantitative computed tomography analysis, airflow obstruction, and lung cancer in the pittsburgh lung screening study.
    Wilson DO; Leader JK; Fuhrman CR; Reilly JJ; Sciurba FC; Weissfeld JL
    J Thorac Oncol; 2011 Jul; 6(7):1200-5. PubMed ID: 21610523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Necessity of organized low-dose computed tomography screening for lung cancer: From epidemiologic comparisons between China and the Western nations.
    Gou HF; Liu Y; Yang TX; Zhou C; Chen XZ
    Oncotarget; 2017 Jan; 8(1):1788-1795. PubMed ID: 27705946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial.
    Brain K; Lifford KJ; Carter B; Burke O; McRonald F; Devaraj A; Hansell DM; Baldwin D; Duffy SW; Field JK
    Thorax; 2016 Nov; 71(11):996-1005. PubMed ID: 27471048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Earlier Diagnosis Not Self-Evidently Beneficial: Natural History of Subcentimeter Lung Cancers.
    Reich JM; Kim JS
    AJR Am J Roentgenol; 2019 Oct; 213(4):817-818. PubMed ID: 31120792
    [No Abstract]   [Full Text] [Related]  

  • 40. Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.
    Sommer G; Wiese M; Winter L; Lenz C; Klarhöfer M; Forrer F; Lardinois D; Bremerich J
    Eur Radiol; 2012 Dec; 22(12):2859-67. PubMed ID: 22772365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.